menu
    • menu

    Company profile for CytRx Corporation

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    EXCIPIENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CytRx is a biopharmaceutical company focused on discovering and developing new therapeutics to treat patients with high unmet needs. CytRx has a milestone and royalty agreement with Orphazyme A/S (“ORPHA.CO”) for arimoclomol. The agreement can provide CytRx with up to $120M in potential milestones + royalties paid on arimoclomol. Orphazyme is currently studying arimoclomol in clinical trials for 4 indications including ...
    CytRx is a biopharmaceutical company focused on discovering and developing new therapeutics to treat patients with high unmet needs. CytRx has a milestone and royalty agreement with Orphazyme A/S (“ORPHA.CO”) for arimoclomol. The agreement can provide CytRx with up to $120M in potential milestones + royalties paid on arimoclomol. Orphazyme is currently studying arimoclomol in clinical trials for 4 indications including Nieman-Pick disease Type C (NPC), amyotrophic lateral sclerosis (ALS), Gaucher disease and sporadic Inclusion Body Myositis (sIBM). Recently, Orpahzyme announced encouraging clinical trial data with arimoclomol in NPC.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CytRx CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    11726 San Vicente Blvd. Suite 650 Los Angeles, California 90049
    Telephone
    Telephone
    (310) 826-5648
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.cytrx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CytRx guns for a reset, rebranding as LadRx
    CytRx guns for a reset, rebranding as LadRx

    26 Sep 2022

    // Ben Adams FIERCEPHARMA

    https://www.fiercepharma.com/marketing/cytrx-guns-reset-new-ceo-ushers-new-era-fresh-re-branding

    Ben Adams FIERCEPHARMA
    26 Sep 2022
    Share Share
    CytRx Corporation Relaunches as LadRx Corporation
    CytRx Corporation Relaunches as LadRx Corporation

    23 Sep 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220923005115/en

    BUSINESSWIRE
    23 Sep 2022
    Share Share
    CytRx Announces Distribution of Series D Preferred Stock to Holders
    CytRx Announces Distribution of Series D Preferred Stock to Holders

    19 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220519005996/en

    BUSINESSWIRE
    19 May 2022
    Share Share
    CytRx Highlights Strategic Purchase of Arimoclomol by KemPharm, Inc.
    CytRx Highlights Strategic Purchase of Arimoclomol by KemPharm, Inc.

    17 May 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220517005567/en

    BUSINESSWIRE
    17 May 2022
    Share Share
    CytRx Partners with Oncology Development Expert to Advance LADR Platform
    CytRx Partners with Oncology Development Expert to Advance LADR Platform

    20 Apr 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220420005357/en

    BUSINESSWIRE
    20 Apr 2022
    Share Share
    CytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progress
    CytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progress

    21 Mar 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220321005328/en

    BUSINESSWIRE
    21 Mar 2022
    Share Share

    Excipients

    Click here to find the perfect excipient manufacturers by their capabilities

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Contact CytRx Corporation and get a quotation

    CytRx Corporation is a supplier offers 2 products (APIs, Excipients or Intermediates).

    Find a price of Cicloxolone bulk offered by CytRx Corporation

    Find a price of Molindone bulk offered by CytRx Corporation

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search